Clinical Trial Update: Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy and safety of zoledronic acid in patients with bone metastases from solid tumors or multiple myeloma; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Multiple Myeloma

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Treatment of Bone Metastases | Phase 3 | Status: COMPLETED